FI914419A0 - Nya insulinfoereningar. - Google Patents

Nya insulinfoereningar.

Info

Publication number
FI914419A0
FI914419A0 FI914419A FI914419A FI914419A0 FI 914419 A0 FI914419 A0 FI 914419A0 FI 914419 A FI914419 A FI 914419A FI 914419 A FI914419 A FI 914419A FI 914419 A0 FI914419 A0 FI 914419A0
Authority
FI
Finland
Prior art keywords
image
coded
amino acid
acid residue
nucleotide sequences
Prior art date
Application number
FI914419A
Other languages
English (en)
Inventor
Per Balschmidt
Finn Benned Hansen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI914419A0 publication Critical patent/FI914419A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI914419A 1989-03-20 1991-09-19 Nya insulinfoereningar. FI914419A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK134189A DK134189D0 (da) 1989-03-20 1989-03-20 Insulinforbindelser
PCT/DK1990/000071 WO1990011299A1 (en) 1989-03-20 1990-03-15 Novel insulin compounds

Publications (1)

Publication Number Publication Date
FI914419A0 true FI914419A0 (fi) 1991-09-19

Family

ID=8103787

Family Applications (1)

Application Number Title Priority Date Filing Date
FI914419A FI914419A0 (fi) 1989-03-20 1991-09-19 Nya insulinfoereningar.

Country Status (23)

Country Link
US (1) US5430016A (fi)
EP (1) EP0463072B1 (fi)
JP (1) JPH04503808A (fi)
KR (1) KR920701250A (fi)
CN (1) CN1045793A (fi)
AT (1) ATE116661T1 (fi)
AU (1) AU637365B2 (fi)
CA (1) CA2049961A1 (fi)
DD (1) DD298788A5 (fi)
DE (1) DE69015811T2 (fi)
DK (2) DK134189D0 (fi)
ES (1) ES2068384T3 (fi)
FI (1) FI914419A0 (fi)
GR (1) GR1002545B (fi)
HU (1) HUT58349A (fi)
IE (1) IE66564B1 (fi)
IL (1) IL93792A0 (fi)
NO (1) NO300640B1 (fi)
NZ (1) NZ232953A (fi)
PT (1) PT93502B (fi)
WO (1) WO1990011299A1 (fi)
YU (1) YU53290A (fi)
ZA (1) ZA902086B (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
DE3844211A1 (de) * 1988-12-29 1990-07-05 Hoechst Ag Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
US5304473A (en) * 1991-06-11 1994-04-19 Eli Lilly And Company A-C-B proinsulin, method of manufacturing and using same, and intermediates in insulin production
TW224471B (fi) * 1991-11-26 1994-06-01 Lilly Co Eli
US5948751A (en) * 1996-06-20 1999-09-07 Novo Nordisk A/S X14-mannitol
JP2001521006A (ja) 1997-10-24 2001-11-06 イーライ・リリー・アンド・カンパニー 不溶性インシュリン組成物
US6531448B1 (en) * 1997-12-23 2003-03-11 Eli Lilly And Company Insoluble compositions for controlling blood glucose
US7378390B2 (en) * 1999-12-29 2008-05-27 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
KR20040070237A (ko) * 2001-12-20 2004-08-06 일라이 릴리 앤드 캄파니 연장된 작용 시간을 갖는 인슐린 분자
BRPI0409600A (pt) * 2003-04-29 2006-04-18 Lilly Co Eli análogo de insulina, composição, método de tratamento de hiperglicemia, e, análogo de pró-insulina
US8622991B2 (en) 2007-03-19 2014-01-07 Insuline Medical Ltd. Method and device for drug delivery
WO2008114224A2 (en) * 2007-03-19 2008-09-25 Insuline Medical Ltd. Method and device for substance measurement
WO2008114223A1 (en) * 2007-03-19 2008-09-25 Insuline Medical Ltd. Drug delivery device
US9220837B2 (en) 2007-03-19 2015-12-29 Insuline Medical Ltd. Method and device for drug delivery
EP2231229A1 (en) 2007-12-18 2010-09-29 Insuline Medical Ltd. Drug delivery device with sensor for closed-loop operation
BRPI0907119A2 (pt) * 2008-01-09 2015-07-14 Sanofi Aventis Deutschland Derivados de insulina tendo um perfil de ação de tempo extremamente retardado
KR20100111682A (ko) 2008-01-09 2010-10-15 사노피-아벤티스 도이칠란트 게엠베하 극히 지연된 시간-작용 프로필을 갖는 신규 인슐린 유도체
KR101820024B1 (ko) 2008-10-17 2018-01-18 사노피-아벤티스 도이칠란트 게엠베하 인슐린과 ｇｌｐ－1 효능제의 병용물
CA2743027C (en) 2008-11-07 2016-04-12 Insuline Medical Ltd. Device and method for drug delivery
ES2534191T3 (es) 2009-11-13 2015-04-20 Sanofi-Aventis Deutschland Gmbh Composición farmacéutica que comprende un agonista de GLP-1, una insulina y metionina
HUE037735T2 (hu) 2009-11-13 2018-09-28 Sanofi Aventis Deutschland DesPro36exendin-4(1-39)-Lys6-NH2-t és metionint tartalmazó gyógyszerkészítmény
BR112013004756B1 (pt) 2010-08-30 2020-04-28 Sanofi Aventis Deutschland uso de ave0010 para a fabricação de um medicamento para o tratamento da diabetes melito tipo 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
RU2650616C2 (ru) 2011-08-29 2018-04-16 Санофи-Авентис Дойчланд Гмбх Фармацевтическая комбинация для применения при гликемическом контроле у пациентов с сахарным диабетом 2 типа
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
WO2014178018A1 (en) 2013-05-02 2014-11-06 Glaxosmithkline Intellectual Property Development Limited Therapeutic peptides
JP6970615B2 (ja) 2014-12-12 2021-11-24 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング インスリングラルギン／リキシセナチド固定比処方
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
CN106323840A (zh) * 2016-09-13 2017-01-11 西南石油大学 一种页岩孔隙度测量方法
CN109735589B (zh) * 2019-01-02 2020-07-10 珠海冀百康生物科技有限公司 一种胰岛素DesB30的制备方法
CN113773398B (zh) * 2020-06-10 2023-05-23 宁波鲲鹏生物科技有限公司 一种德谷胰岛素衍生物及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55138393A (en) * 1979-04-13 1980-10-29 Shionogi & Co Ltd Semisynthesis of insulin
IE50892B1 (en) * 1980-02-11 1986-08-06 Novo Industri As Process for preparing insulin esters
DK147437A (en) * 1980-02-11 1900-01-01 Process for preparing human insulin or threonine B30 esters of human insulin, or a salt or complex thereof
DE3326472A1 (de) * 1983-07-22 1985-02-14 Hoechst Ag, 6230 Frankfurt Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
DE3327709A1 (de) * 1983-07-29 1985-02-07 Hoechst Ag, 6230 Frankfurt Insulin-derivat-kristallsuspensionen, verfahren zu deren herstellung und deren verwendung
DK58285D0 (da) * 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
US4946828A (en) * 1985-03-12 1990-08-07 Novo Nordisk A/S Novel insulin peptides
DK113585D0 (da) * 1985-03-12 1985-03-12 Novo Industri As Nye peptider
US5008241A (en) * 1985-03-12 1991-04-16 Novo Nordisk A/S Novel insulin peptides
DK347086D0 (da) * 1986-07-21 1986-07-21 Novo Industri As Novel peptides
DK119785D0 (da) * 1985-03-15 1985-03-15 Nordisk Gentofte Insulinpraeparat
DK129385A (da) * 1985-03-22 1986-09-23 Novo Industri As Peptider og fremstilling deraf
DK437786D0 (da) * 1986-09-12 1986-09-12 Nordisk Gentofte Insulinprecursorer
DE3717370A1 (de) * 1987-05-22 1988-12-01 Hoechst Ag Mischkristalle aus insulin und insulinderivaten, verfahren zur herstellung dieser mischkristalle, diese mischkristalle enthaltende pharmazeutische mittel und ihre verwendung zur behandlung von diabetes mellitus
DK336188D0 (da) * 1988-06-20 1988-06-20 Nordisk Gentofte Propeptider
DE3844211A1 (de) * 1988-12-29 1990-07-05 Hoechst Ag Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung

Also Published As

Publication number Publication date
NO913687D0 (no) 1991-09-19
DK0463072T3 (da) 1995-06-12
US5430016A (en) 1995-07-04
PT93502B (pt) 1996-02-29
CA2049961A1 (en) 1990-09-21
DE69015811T2 (de) 1995-05-11
GR900100206A (el) 1991-07-31
AU637365B2 (en) 1993-05-27
ATE116661T1 (de) 1995-01-15
EP0463072B1 (en) 1995-01-04
YU53290A (sh) 1992-12-21
NO913687L (no) 1991-11-19
AU5344890A (en) 1990-10-22
DD298788A5 (de) 1992-03-12
IL93792A0 (en) 1990-12-23
KR920701250A (ko) 1992-08-11
HUT58349A (en) 1992-02-28
IE901004L (en) 1990-09-20
ZA902086B (en) 1990-11-28
DK134189D0 (da) 1989-03-20
WO1990011299A1 (en) 1990-10-04
ES2068384T3 (es) 1995-04-16
EP0463072A1 (en) 1992-01-02
CN1045793A (zh) 1990-10-03
NO300640B1 (no) 1997-06-30
HU902706D0 (en) 1991-12-30
IE66564B1 (en) 1996-01-24
DE69015811D1 (de) 1995-02-16
GR1002545B (el) 1997-01-28
PT93502A (pt) 1990-11-07
NZ232953A (en) 1992-10-28
JPH04503808A (ja) 1992-07-09

Similar Documents

Publication Publication Date Title
FI914419A0 (fi) Nya insulinfoereningar.
AU4799793A (en) Beta -aminoalkyl and beta -n-peptidylaminoalkyl boronic acids
DK0585285T3 (da) Stabiliserede enzymer
NZ220546A (en) Benzothiophene- and benzofuran- amides and compositions
AU6954887A (en) Oligopeptidyl nitrile derivatives, agents containing them, a process for their preparation, and their use
ES8501364A1 (es) Un metodo para la preparacion de nuevos polipeptidos.
NO971621L (no) Keratinocyttvekstfaktoranaloger
ATE41154T1 (de) Verfahren zur herstellung alkanphosphoniger saeuren.
ES8407011A1 (es) Un procedimiento para la preparacion de un derivado de un peptido ciclico a-21978c.
DE69814837D1 (de) Verfahren zur Herstellung von Heteroaryl-Zink-Halogeniden
MX173831B (es) Compuestos de naftil-azo-pirazolona y procedimiento para la preparacion de los mismos
AR241084A2 (es) Compuestos derivados de piridazina, formulacion y composicion fungicida que los comprende y procedimiento para prepararlos".
DK0661263T3 (da) Fremgangsmåde til fremstilling af 2,4,5-tribrompyrrol-3-carbonitril
IL109978A0 (en) Ureins derived from alpha,omega-diamino acids and their preparation
EP0506971A4 (en) Peptide with activity of inhibiting phospholipase a2 originating in inflamed part
ES2003196A6 (es) Procedimiento de obtencion de nuevos acidos 1-etil-6-fluor-7-heterociclilamino-1,4-dihidro-4-oxoquinolin-3-carboxilicos
JPS5283829A (en) Cyclic compound
ATE118211T1 (de) Verfahren zur herstellung 2-methoxyimino-2- (5- amino-1,2,4-thiadiazol-3-yl)essigsäure oder ihrer salze.
EP0684253A4 (en) DESALANINE LEVEL ANOMICIN A DERIVATIVES AND PRODUCTION THEREOF.
ES8702900A1 (es) Procedimiento de obtencion de un compuesto de guanidiltia- zol, util como inhibidor de secrecion gastrica